These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9532276)

  • 1. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    Preul MC; Leblanc R; Caramanos Z; Kasrai R; Narayanan S; Arnold DL
    Can J Neurol Sci; 1998 Feb; 25(1):13-22. PubMed ID: 9532276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
    Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
    Chang J; Thakur S; Perera G; Kowalski A; Huang W; Karimi S; Hunt M; Koutcher J; Fuks Z; Amols H; Narayana A
    Med Phys; 2006 Jan; 33(1):32-40. PubMed ID: 16485406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma.
    Ballangrud AM; Lymberis S; Thakur SB; Karimi S; Huang W; Abrey LE; Beal K; Iwamoto FM; Brennan C; Gutin PH; Chang J
    Med Phys; 2011 May; 38(5):2724-30. PubMed ID: 21776809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
    Ganslandt O; Stadlbauer A; Fahlbusch R; Kamada K; Buslei R; Blumcke I; Moser E; Nimsky C
    Neurosurgery; 2005 Apr; 56(2 Suppl):291-8; discussion 291-8. PubMed ID: 15794826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.
    Hein PA; Eskey CJ; Dunn JF; Hug EB
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):201-9. PubMed ID: 14970018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.
    Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Bonavita S; de Cristofaro M; Conforti R; Cristofano A; Colonnese C; Salvolini U; Tedeschi G
    Radiol Med; 2014 Aug; 119(8):616-24. PubMed ID: 24408041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.
    Rabinov JD; Lee PL; Barker FG; Louis DN; Harsh GR; Cosgrove GR; Chiocca EA; Thornton AF; Loeffler JS; Henson JW; Gonzalez RG
    Radiology; 2002 Dec; 225(3):871-9. PubMed ID: 12461273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
    Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.
    Rock JP; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rosenblum M; Mikkelsen T
    Neurosurgery; 2004 May; 54(5):1111-7; discussion 1117-9. PubMed ID: 15113465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
    Taylor JS; Langston JW; Reddick WE; Kingsley PB; Ogg RJ; Pui MH; Kun LE; Jenkins JJ; Chen G; Ochs JJ; Sanford RA; Heideman RL
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1251-61. PubMed ID: 8985051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.